Financials
Financial year 2025
BONIMEDIC from Verviers, company number BE0867744281, closed financial year 2025 with a result of € 106,335 after tax. For that financial year BONIMEDIC recorded a gross margin of € 272,538 and equity of € 376,898. Compared with financial year 2024, the result moved from € 67,244 to € 106,335. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.
€ 376,898
▲ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 106,335
▲ 58% vs 2024
Profit after tax over the fiscal year.
€ 87,052
▼ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 89,343 paid out
84 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 39,439
▼ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 39,796
▲ 168% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 173,879
▼ 27% vs 2024
€ 41,046 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 1,759
▼ 48% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 20,537
▼ 17% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 187,505 | € 207,448 | € 212,636 | € 272,538 | ▲ 28% |
| Profit after taxes | € 44,953 | € 53,939 | € 67,244 | € 106,335 | ▲ 58% |
| Equity | € 290,723 | € 292,662 | € 359,906 | € 376,898 | ▲ 5% |
| Total debts | € 438,137 | € 354,605 | € 271,499 | € 246,796 | ▼ 9% |
| Cash | € 37,697 | € 36,904 | € 102,423 | € 87,052 | ▼ 15% |
| Land & buildings | € 548,534 | € 495,097 | € 439,392 | € 398,743 | ▼ 9% |
| Retained profit | € 272,123 | € 274,062 | € 341,306 | € 358,298 | ▲ 5% |
| Dividend | € 0 | € 52,000 | € 0 | € 89,343 | |
| Bank debt | € 375,558 | € 307,681 | € 239,442 | € 173,879 | ▼ 27% |
| Balance sheet total | € 728,860 | € 647,267 | € 631,405 | € 623,694 | ▼ 1% |
Key figures of BONIMEDIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BONIMEDIC?
What happened at BONIMEDIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Catherine BRAHAM stepped down as director. NBB
- Vincent BONIVER stepped down as director. NBB
- Raymond BONIVER stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 106,335 (▲ 58% vs 2024). Source: NBB ↗
- Catherine BRAHAM became a director. NBB
- Vincent BONIVER became a director. NBB
- Raymond BONIVER became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 44,953 profit in 2022 to € 106,335 profit in 2025.
Paid € 115,957 in corporate taxes since 2022.
Best year ever: 2025, with € 106,335 profit.
Paid out € 141,343 in dividends to the owners in total.
A new publication or filing at BONIMEDIC? We notify you, reason included.
Follow BONIMEDICDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Vincent BONIVER
Director
since 2020 · until 2040
Catherine BRAHAM
Director
since 2025 · until 2045
Raymond BONIVER
Director
since 2020 · until 2040
Establishments
Establishment units
Physical locations of this company
Rue de Bruxelles 21
4800 Verviers
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0867.744.281
- VAT number
- BE 0867.744.281
- Registered office
- Rue de Bruxelles 21, 4800 Verviers
- Names & denominations
- BONIMEDIC
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 October 2004
- Peppol
- Active · Active since 9 Oct 2025
- Activities · NACE
Activiteiten van huisartspraktijken
Medische praktijken
Activiteiten van medisch specialisten